Sale of 33,818 shares at $36.44 per share.
Reporting Person Venker Eric · Officer Title President & Immunovant CEO · Transaction Code S
Traded Aug 28, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0001140361-26-035375 · filed 2026-09-01 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Roivant Sciences Ltd. (ROIV)." Disclosed 2026-09-01. https://desqlong.com/cards/0001140361-26-035375-3 (retrieved 2026-09-26).